LPC18 :0 Secreted by Exogenous Neural Stem Cells Potentiates Neurogenesis and Functional Recovery via GPR55 ‐Mediated Signalling in Spinal Cord Injury
Cell Proliferation · 2025
DOI: 10.1111/cpr.70146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Dong Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Neural Stem Cells, Neurogenesis, Receptors, G-Protein-Coupled. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province of China, Nanjing Municipal Health Science and Technology Development Special Fund Project.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a devastating condition with limited therapeutic options. Although neural stem cell (NSC) transplantation shows regenerative potential, its efficacy is constrained by the hostile post‐injury microenvironment. Here, we employed untargeted metabolomics to investigate metabolic reprogramming induced by NSC‐loaded multichannel collagen scaffolds in a rat SCI model. NSC transplantation significantly enhanced functional recovery and structural remodelling, concomitant with elevated neurogenesis and attenuated gliosis. Metabolomic profiling identified lysophosphatidylcholine 18:0 (LPC18:0) as a key NSC‐derived metabolite. Mechanistically, LPC18:0 promoted the differentiation of endogenous NSCs into neurons via the GPR55/AKT/GSK3β signalling axis, as validated by receptor‐specific inhibition. In vivo administration of LPC18:0 improved motor function, axonal regeneration and recruitment of immature neurons. These findings reveal a novel metabolic mechanism underlying NSC‐based therapy, positioning LPC18:0/GPR55/AKT/GSK3β signalling as a therapeutic target for SCI recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- State Key Laboratory of Pharmaceutical Biotechnology and Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, School of Life Sciences, Nanjing University, Nan…
- Clinical Stem Cell Center, Nanjing Drum Tower Hospital, Clinical Medical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- China Hospital Reform and Development Research Institute of Nanjing University, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
ORCID-Profile: Bin Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province of China
- Nanjing Municipal Health Science and Technology Development Special Fund Project
Zitieren
APA
Chen, D., Liu, S., Tu, L. Y., Yang, M. M., Xu, C. W., Jiang, Y., Yang, H., Tai, C. X., Wang, Y. N., Xie, Y. Y., Shen, P. P., & Wang, B. (2025). LPC18 :0 Secreted by Exogenous Neural Stem Cells Potentiates Neurogenesis and Functional Recovery via GPR55 ‐Mediated Signalling in Spinal Cord Injury. Cell Proliferation. https://doi.org/10.1111/cpr.70146
Vancouver
Chen D, Liu S, Tu LY, Yang MM, Xu CW, Jiang Y, et al. LPC18 :0 Secreted by Exogenous Neural Stem Cells Potentiates Neurogenesis and Functional Recovery via GPR55 ‐Mediated Signalling in Spinal Cord Injury. Cell Proliferation. 2025. doi:10.1111/cpr.70146
BibTeX
@article{Chen2025,
author = {Chen, Dong and Liu, Shuo and Tu, Le-Yi and Yang, Ming-Mei and Xu, Cong-Wang and Jiang, Yue and Yang, Hui and Tai, Chen-Xu and Wang, Yan-Ning and Xie, Yuan-Yuan and Shen, Ping-Ping and Wang, Bin},
title = {LPC18 :0 Secreted by Exogenous Neural Stem Cells Potentiates Neurogenesis and Functional Recovery via GPR55 ‐Mediated Signalling in Spinal Cord Injury},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.70146}
}
EUVIMED